文献速递血液透析通路

矿物质代谢紊乱与动静脉瘘成熟的关系

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-04-15

本研究基于血液透析瘘管成熟研究的多中心前瞻性队列,检测562例自体上肢动静脉瘘患者的术前血清矿物质代谢标志物,未发现其与静脉组织学特征或瘘管成熟失败显著相关(除24,25(OH)2D与总体失败存在生物学无法解释的关联外)。

要点

  • 术前血清FGF23、PTH、钙、磷及维生素D代谢物与静脉组织学特征无显著关联。
  • 矿物质代谢标志物与无辅助或总体AVF成熟失败无显著关联(除一项无法解释的关联)。
  • 提高AVF成熟率应关注静脉力学、解剖及细胞代谢等其他过程。

核心结论

  • 测定的血清矿物质代谢物与AVF创建手术患者的静脉主要组织学特征或AVF成熟失败无实质性关联。

研究设计与样本

  • 多中心前瞻性队列研究,纳入602例参与者中的562例术前血清样本,检测FGF23、PTH、钙、磷及维生素D代谢物。
  • 无辅助和总体AVF成熟分别在540和527例参与者中评估,随访至术后9个月或透析开始后4周。
  • 取吻合静脉邻近段,测量新内膜增生、钙化和中膜胶原沉积。

主要发现

  • 参与者71%男性,43%黑人,平均年龄55岁。
  • 288例(53%)参与者无辅助AVF成熟失败。
  • 除24,25(OH)2D较高与总体失败存在生物学无法解释的关联外,矿物质代谢标志物与静脉组织学特征、无辅助AVF成熟失败或总体成熟失败均无显著关联。
  • 连续变量、分类变量及相关亚组分析中关联均不显著。

临床怎么用

  • 对于接受AVF手术的终末期肾病患者,术前矿物质代谢标志物可能不是静脉组织学或AVF成熟的可靠预测指标。
  • 改善AVF成熟率的策略应更多关注静脉力学、解剖和细胞代谢等其他过程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The arteriovenous fistula (AVF) is central to haemodialysis treatment, but up to half of surgically created AVF fail to mature. Chronic kidney disease often leads to mineral metabolism disturbances that may interfere with AVF maturation through adverse vascular effects. This study tested associations between mineral metabolism markers and vein histology at AVF creation and unassisted and overall clinical AVF maturation. METHODS: Concentrations of fibroblast growth factor 23, parathyroid hormone, calcium, phosphate, and vitamin D metabolites: 1,25(OH)2D, 24,25(OH)2D, 25(OH)D, and bioavailable 25(OH)D were measured in pre-operative serum samples from 562 of 602 participants in the Haemodialysis Fistula Maturation Study, a multicentre, prospective cohort study of patients undergoing surgical creation of an autologous upper extremity AVF. Unassisted and overall AVF maturation were ascertained for 540 and 527 participants, respectively, within nine months of surgery or four weeks of dialysis initiation. Study personnel obtained vein segments adjacent to the portion of the vein used for anastomosis, which were processed, embedded, and stained for measurement of neointimal hyperplasia, calcification, and collagen deposition in the medial wall. RESULTS: Participants in this substudy were 71% male, 43% black, and had a mean age of 55 years. Failure to achieve AVF maturation without assistance occurred in 288 (53%) participants for whom this outcome was determined. In demographic and further adjusted models, mineral metabolism markers were not significantly associated with vein histology characteristics, unassisted AVF maturation failure, or overall maturation failure, other than a biologically unexplained association of higher 24,25(OH)2D with overall failure. This exception aside, associations were non-significant for continuous and categorical analyses and relevant subgroups. CONCLUSIONS: Serum concentrations of measured mineral metabolites were not substantially associated with major histological characteristics of veins in patients undergoing AVF creation surgery, or with AVF maturation failure, suggesting that efforts to improve AVF maturation rates should increase attention to other processes such as vein mechanics, anatomy, and cellular metabolism among end stage renal disease patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kubiak RW, Zelnick LR, Hoofnagle AN, et al. Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation. Eur J Vasc Endovasc Surg. 2019. PMID: 31000459. doi:10.1016/j.ejvs.2019.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。